Skip to main content
logo
AIM ImmunoTech Inc. (AIM)
NYSEAMERICAN: AIM · Real-Time Price · USD
9.09
-0.27 (-2.88%)
Jul 11, 2025, 4:00 PM - Market closed

AIM ImmunoTech Revenue

AIM ImmunoTech had revenue of $16.00K in the quarter ending March 31, 2025, a decrease of -60.00%. This brings the company's revenue in the last twelve months to $146.00K, down -24.35% year-over-year. In the year 2024, AIM ImmunoTech had annual revenue of $170.00K, down -15.84%.

Revenue (ttm)
$146.00K
Revenue Growth
-24.35%
P/S Ratio
49.23
Revenue / Employee
$6,348
Employees
23
Market Cap
7.19M

Revenue Chart

Revenue History

Fiscal Year End Revenue Change Growth
Dec 31, 2024 170.00K -32.00K -15.84%
Dec 31, 2023 202.00K 61.00K 43.26%
Dec 31, 2022 141.00K 6.00K 4.44%
Dec 31, 2021 135.00K -28.00K -17.18%
Dec 31, 2020 163.00K 23.00K 16.43%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 410.06B
Johnson & Johnson 89.33B
Merck & Co. 63.92B
AbbVie 57.37B
AstraZeneca 54.98B
Novartis AG 53.22B
Eli Lilly and Company 49.00B
Novo Nordisk 43.92B
Revenue Rankings

AIM News

More News